article thumbnail

PhoreMost unveils platform to streamline molecular glue drug discovery

Pharma Times

The data supports the platform’s potential to accelerate drug development programmes and expand the druggable proteome. Dr Benedict Cross, CTO, PhoreMost, said: “Molecular glues have now been established as an effective therapeutic modality, but these small molecule drugs have still largely only been found through serendipity.

article thumbnail

What are the Top Pharma Podcasts in 2025?

Pharma Marketing Network

Table of Contents Why Pharma Podcasts Are Gaining Momentum The Best Pharma Marketing Podcasts in 2025 Top Drug Development and Biotech Podcasts Emerging Voices and Niche Pharma Shows Conclusion and FAQs Why Pharma Podcasts Are Gaining Momentum In today’s information-saturated world, audio content has carved out a unique advantage.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AZ boasts phase 3 win for self-administered gMG drug

pharmaphorum

Skip to main content Thursday 24 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

With ADCs on the rise, drugmakers embrace a new oncology pillar

PharmaVoice

Getting the drug-to-antibody ratio correct and a stabilized linker to deliver a potent payload without too many off-target effects has been the goal for drug developers. “It’s only been around the last five years where many of these challenges have been resolved.”

article thumbnail

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

Pharmacy Times

Historically, the FDA has required preclinical testing in animals to obtain safety and efficacy data for investigational new drugs (INDs) before they can begin clinical testing in humans. The FDA plan seeks to leverage existing new technology in drug development.

article thumbnail

Strategies For A Pharma Ad Ban on TV

Pharma Marketing Network

Email marketing campaigns can keep healthcare professionals informed about drug developments. Podcasts and webinars allow industry experts to provide in-depth insights about medications. Physician networking webinars discussing treatment advancements. SEO-optimized blog content helps brands rank higher in search results.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

CMS is issuing unique J-codes for 505(b)(2) drugs, classifying them as sole-source products if not therapeutically equivalent. This pathway reduces submission denial risk, accelerates drug development, and offers potential market exclusivity for up to 7 years.